1 Min Read
Jan 29 (Reuters) - Masimo Corp:
* MASIMO CORP - ANNOUNCED FDA CLEARANCE OF NEXT GENERATION SEDLINE BRAIN FUNCTION MONITORING Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.